Rest of world — Revenue
Eli Lilly Rest of world — Revenue increased by 26.5% to $2.77B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 177.9%, from $997.00M to $2.77B. Over 3 years (FY 2022 to FY 2025), Rest of world — Revenue shows an upward trend with a 28.5% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates successful international market penetration and growing global demand for the company's therapeutic offerings, while a decrease may signal competitive pressure or regulatory hurdles in foreign markets.
Detailed definition
This metric represents the total net sales generated by the company from geographic regions outside of its primary domes...
Peer comparison
Peers typically report this as 'International Revenue' or 'Revenue by Geography,' and it is often compared against total revenue to determine the company's global footprint.
lly_segment_rest_of_world_revenueHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $713.00M | $713.00M | $713.00M | $713.00M | $736.50M | $736.50M | $736.50M | $736.50M | $892.90M | $1.21B | $1.11B | $1.06B | $997.00M | $1.18B | $1.69B | $2.19B | $2.77B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +3.3% | +0.0% | +0.0% | +0.0% | +21.2% | +35.1% | -8.1% | -4.0% | -6.3% | +18.6% | +42.8% | +29.8% | +26.5% |
| YoY Change | — | — | — | — | +3.3% | +3.3% | +3.3% | +3.3% | +21.2% | +63.8% | +50.5% | +44.5% | +11.7% | -2.0% | +52.3% | +105.8% | +177.9% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Eli Lilly's rest of world — revenue?
- Eli Lilly (LLY) reported rest of world — revenue of $2.77B in Q1 2026.
- How has Eli Lilly's rest of world — revenue changed year-over-year?
- Eli Lilly's rest of world — revenue increased by 177.9% year-over-year, from $997.00M to $2.77B.
- What is the long-term trend for Eli Lilly's rest of world — revenue?
- Over 3 years (2022 to 2025), Eli Lilly's rest of world — revenue has grown at a 28.5% compound annual growth rate (CAGR), from $2.85B to $6.06B.
- What does rest of world — revenue mean?
- The total revenue earned by the company from all countries excluding its home market.